Examples of Aquavan in a sentence
The Grantor has (or will have at the time it acquires rights in Collateral hereafter acquired or arising) and will maintain so long as the Security Interest may remain outstanding, title (as owner or licensee) to each item of Collateral (including the proceeds and products thereof), free and clear of all Liens except (i) the Security Interest and (ii) the existing license in favor of Guilford with respect to Aquavan.
MGI said doctors were able to complete the bronchoscopy 91.3 percent of the time when the patients were given Aquavan, and 41.2 percent when the patients received the control drug.
Hypoxemia was observed in 15 percent of the patients who were given Aquavan, and 13 percent of patients receiving the control drug.
In 2002, the Company achieved a development milestone related to Aquavan, which resulted in a payment due to ProQuest of $0.8 million and the Company receiving additional shares of the common stock of ProQuest.
Driven primarily by the pivotal development program for Aquavan and pre-launch costs, the net reduction of pre-tax income in 2006 and 2007 is expected to be approximately $35 million and $25 million, respectively.
A randomized, double-blind, multi-center, pivotal phase 3 trial of Aquavan Injection for sedation of patients undergoing bronchoscopy successfully met the primary endpoint of sedation success as well as all secondary endpoints.
Proceeds from the equity issuance are being used to fund clinical trials for Aquavan and Aggrastat, further develop the Company’s pre-clinical product candidates and for general corporate purposes.
With this transaction, the Company obtained full ownership of the worldwide intellectual property rights to Aquavan, which is currently in Phase III clinical trials, and received cash, net of liabilities assumed, of less than $0.1 million (see Note 3).
Our late stage product candidates include two product candidates from our acute care franchise (Aloxi for post operative nausea and vomiting (“PONV”) and Aquavan, a minimal to moderate sedative agent for patients undergoing brief diagnostic or surgical procedures), oncology (Dacogen for acute myeloid leukemia (“AMY”)) and supportive care (Saforis Powder for Oral Suspension (“Saforis”)) products, as well as a biologics candidate, arnolimogene bepiplasmid.
MGI Pharma has been granted a first priority interest in the NAALADase inhibitor Compounds and PARP inhibitor Compounds and in the Aquavan intellectual property and related assets (but excluding, in each case, any collateral in which PRF has a security interest.) In addition, if the Merger Agreement is terminated without closing, the Company has a 90-day right to sell its Gliadel business to MGI Pharma for a purchase price of $90.0 million.